About Istanbul Medeniyet Uni Goztepe Training&Res Hosp
Clinical Trials at Istanbul Medeniyet Uni Goztepe Training&Res Hosp
During the past decade, Istanbul Medeniyet Uni Goztepe Training&Res Hosp conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 2 clinical trials were completed, i.e. on
average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Istanbul Medeniyet Uni Goztepe Training&Res Hosp" #1 sponsor was "Celgene" with 6 trials, followed by "Hoffmann-La Roche" with 5 trials
sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "BeiGene" with 2 trials sponsored and "Basilea Pharmaceutica"
with 2 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Istanbul Medeniyet Uni Goztepe Training&Res Hosp"
#1 collaborator was "Turkish Society of Anesthesiology and Reanimation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Istanbul Medeniyet Uni Goztepe Training&Res Hosp
According to Clinical.Site data, the most researched conditions in "Istanbul Medeniyet Uni Goztepe Training&Res Hosp" are
"Crohn Disease" (7 trials), "Non-small Cell Lung Cancer" (2 trials), "Urinary Bladder Neoplasms" (2 trials), "Anemia" (1 trials) and "Blood Loss Anemia" (1 trials). Many other conditions were trialed in "Istanbul Medeniyet Uni Goztepe Training&Res Hosp" in a lesser frequency.
Clinical Trials Intervention Types at Istanbul Medeniyet Uni Goztepe Training&Res Hosp
Most popular intervention types in "Istanbul Medeniyet Uni Goztepe Training&Res Hosp" are "Drug" (19 trials), "Other" (5 trials), "Biological" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Atezolizumab" (3 trials), "Cetrelimab" (3 trials), "Cisplatin" (3 trials) and "GED-0301" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Istanbul Medeniyet Uni Goztepe Training&Res Hosp
The vast majority of trials in "Istanbul Medeniyet Uni Goztepe Training&Res Hosp" are
21 trials for "All" genders.
Clinical Trials Status at Istanbul Medeniyet Uni Goztepe Training&Res Hosp
Currently, there are NaN active trials in "Istanbul Medeniyet Uni Goztepe Training&Res Hosp".
undefined are not yet recruiting,
9 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Istanbul Medeniyet Uni Goztepe Training&Res Hosp,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Istanbul Medeniyet Uni Goztepe Training&Res Hosp, 2 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 15 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".